Telmiprime CH 40mg/12.5mg Tablet
By Telmiprime CH
Rx
15 Tablet in a Strip

Composition
Telmisartan(40mg) + Chlorthalidone(12.5mg)

Manufacturer - Primus Remedies Pvt Ltd
Primus Remedies Pvt Ltd, C-16, Ankur Cooperative Society, Thakurli Estate, Dombivili, Mumbai-421202.

Expires on or after
April, 2027

liver
Telmiprime CH 40mg/12.5mg Tablet should be used carefully by individuals with liver disease. It may be necessary to adjust the dosage of Telmiprime CH 40mg/12.5mg Tablet for these patients. Consulting your doctor is important in such cases. It is advised not to use Telmiprime CH 40mg/12.5mg Tablet in individuals with severe liver disease.

kidney
Telmiprime CH 40mg/12.5mg Tablet should be used carefully in severe kidney disease. Dose adjustment may be necessary. Avoid in these patients; consult your doctor.

alcohol
It is unsafe to drink alcohol while taking Telmiprime CH 40mg/12.5mg Tablet.

driving
Telmiprime CH 40mg/12.5mg Tablet may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Telmiprime CH 40mg/12.5mg Tablet is not recommended during pregnancy because it poses risks to the developing baby. In certain life-threatening situations, a doctor might prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Telmiprime CH 40mg/12.5mg Tablet is not recommended for use during breastfeeding as it may cause toxicity to the baby. It is better to consult your doctor before using Telmiprime CH 40mg/12.5mg Tablet.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | CARDIAC |
| Action Class | - |
₹183.45
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024
